1383385-64-5 | N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

1383385-64-5    1422827-96-0    1688705-42-1 

[1]CurrentPatentAssignee:ABBVIEINC-WO2015/48689,2015,A1Locationinpatent:Paragraph00523

14547-83-2    73183-34-3    1383385-64-5 

[1]CurrentPatentAssignee:HANGZHOUMEDICALCOLLEGE-CN113968860,2022,ALocationinpatent:Paragraph0041-0043

[2]CurrentPatentAssignee:NANJINGGENTAIPHARMACEUTICALTECH-CN106831789,2017,ALocationinpatent:Paragraph0095;0096;0097;0098

[3]CurrentPatentAssignee:NANJINGTRANSTHERABIOSCIENCES;TRANSTHERASCIENCESNANJING-CN110964016,2020,ALocationinpatent:Paragraph0076-0078;0082-0084

[4]CurrentPatentAssignee:ABBVIEINC-WO2015/48689,2015,A1Locationinpatent:Paragraph00493;00496;00545

[5]CurrentPatentAssignee:SHANGHAIDUDEMEDICALTECHNOLOGY-CN109111446,2019,ALocationinpatent:Paragraph0250;0251;0252

[6]Ma,Yuwen;Leng,Taohua;Lai,Guoqiao;Li,Zhifang;Xu,Xiaojia;Zou,Jianwei;Shen,Yongjia;Wang,Chengyun[Tetrahedron,2016,vol.72,#17,p.2219-2225]

[7]Ma,Yuwen;Leng,Taohua;Qu,Yarong;Wang,Chengyun;Shen,Yongjia;Zhu,Weihong[Tetrahedron,2017,vol.73,#1,p.14-20]

[8]CurrentPatentAssignee:SUNPHARMAADVANCEDRESEARCHCOMPANYLIMITED-WO2018/2958,2018,A1Locationinpatent:Page/Pagecolumn36

[9]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN107759602,2018,ALocationinpatent:Paragraph0160-0161;0164

[10]CurrentPatentAssignee:BIOCADHOLDINGLTD-WO2018/92047,2018,A1Locationinpatent:Page/Pagecolumn127

[11]CurrentPatentAssignee:SHANDONGUNIVERSITY-CN111018865,2020,ALocationinpatent:Paragraph0092-0094

[12]CurrentPatentAssignee:NANJINGCORETECHBIOMEDICAL-CN111377928,2020,ALocationinpatent:Paragraph0044-0045

[13]CurrentPatentAssignee:SHANDONGUNIVERSITY-CN111662296,2020,ALocationinpatent:Paragraph0093;0127;0128

[14]Ran,Fansheng;Liu,Yang;Chen,Xin;Zhuo,Huijun;Xu,Changqing;Li,Yuxia;Duan,Xiaoming;Zhao,Guisen[BioorganicChemistry,2021,vol.112]

[15]CurrentPatentAssignee:NATCOPHARMALIMITED-WO2021/111465,2021,A1Locationinpatent:Page/Pagecolumn18

1276110-38-3   

N-(pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 

 

(R)-tert-butyl3-(4-amino-3-(4-(pyridin-2-ylcarbamoyl)phenyl)-1H-pyrazolo3,4-dpyrimidin-1-yl)piperidine-1-carboxylate 

[1]CurrentPatentAssignee:ABBVIEINC-WO2015/48689,2015,A1Locationinpatent:Paragraph00547

[2]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN107759602,2018,ALocationinpatent:Paragraph0317;0320-0321

504-29-0    1383385-64-5 

[1]CurrentPatentAssignee:ABBVIEINC-WO2015/48689,2015,A1

[2]Ma,Yuwen;Leng,Taohua;Lai,Guoqiao;Li,Zhifang;Xu,Xiaojia;Zou,Jianwei;Shen,Yongjia;Wang,Chengyun[Tetrahedron,2016,vol.72,#17,p.2219-2225]

[3]Ma,Yuwen;Leng,Taohua;Qu,Yarong;Wang,Chengyun;Shen,Yongjia;Zhu,Weihong[Tetrahedron,2017,vol.73,#1,p.14-20]

[4]CurrentPatentAssignee:NANJINGGENTAIPHARMACEUTICALTECH-CN106831789,2017,A

[5]CurrentPatentAssignee:SUNPHARMAADVANCEDRESEARCHCOMPANYLIMITED-WO2018/2958,2018,A1

[6]CurrentPatentAssignee:BIOCADHOLDINGLTD-WO2018/92047,2018,A1

[7]CurrentPatentAssignee:SUZHOUPENGXUPHARMATECHCO.,LTD.-WO2019/90269,2019,A1

[8]CurrentPatentAssignee:NANJINGTRANSTHERABIOSCIENCES;TRANSTHERASCIENCESNANJING-CN110964016,2020,A

[9]CurrentPatentAssignee:SHANDONGUNIVERSITY-CN111018865,2020,A

[10]CurrentPatentAssignee:NANJINGCORETECHBIOMEDICAL-CN111377928,2020,A

[11]CurrentPatentAssignee:SHANDONGUNIVERSITY-CN111662296,2020,A

[12]Ran,Fansheng;Liu,Yang;Chen,Xin;Zhuo,Huijun;Xu,Changqing;Li,Yuxia;Duan,Xiaoming;Zhao,Guisen[BioorganicChemistry,2021,vol.112]

[13]CurrentPatentAssignee:HANGZHOUMEDICALCOLLEGE-CN113968860,2022,A

1383385-64-5    1688705-25-0    1688704-75-7 

[1]CurrentPatentAssignee:ABBVIEINC-WO2015/48689,2015,A1Locationinpatent:Paragraph00490;00576